Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn about the various fees that may come with cash back credit cards. Equip yourself with this knowledge before applying.
22,981 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A bold treasury move turned Bitcoin into dividends. This practical look at a BTC monetization program reveals how lar...
GLPI's Q4 2025 results show growth, margin trends, and clearer guidance for 2026. This analysis translates the number...
Memory chips power AI and data centers, but prices swing with cycles. This guide weighs whether micron stock bubble r...
A growth stock has fallen over 40% in 2026, testing the patience of investors. This guide breaks down how to assess w...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
This in-depth guide breaks down what to watch in Ziff Davis's Q1 2026 earnings transcript, how growth drivers shape t...
Ciena’s shares jumped sharply in the first half of 2026. This article dives into the AI-driven demand for optical net...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...